methylphenidate has been researched along with Acquired Immune Deficiency Syndrome in 4 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seven patients with AIDS-related cognitive and emotional deficits had neuropsychologic testing and then were treated with methylphenidate or dextroamphetamine in individualized doses." | 2.67 | Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment. ( Angrist, B; d'Hollosy, M; Diamond, G; Sanfilipo, M; Satriano, J; Simberkoff, M; Weinreb, H, 1992) |
| "Bereavement after diagnosing AIDS or other HIV disease, psychological symptoms secondary to brain disease and the social consequences of having AIDS all interact to produce a devastating illness where the patient may be intensely grieving, demented and totally rejected by all of society." | 1.27 | Psychosocial aspects of AIDS. ( Goldmeier, D, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angrist, B | 1 |
| d'Hollosy, M | 1 |
| Sanfilipo, M | 1 |
| Satriano, J | 1 |
| Diamond, G | 1 |
| Simberkoff, M | 1 |
| Weinreb, H | 1 |
| Walling, VR | 1 |
| Pfefferbaum, B | 1 |
| Fernandez, F | 1 |
| Levy, JK | 1 |
| Galizzi, H | 1 |
| Goldmeier, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Conscious Dying/Conscious Living: Ketamine-Assisted Psychotherapy (KAP) for Patients at End of Life-A Pilot Study for Palliative and Hospice Care[NCT05214417] | Phase 2 | 120 participants (Anticipated) | Interventional | 2022-05-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for methylphenidate and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Dextroamphetamine; Humans; Male; Mental Disorders; Methyl | 1992 |
3 other studies available for methylphenidate and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
The use of methylphenidate in a depressed adolescent with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Child Abuse; Depressive Disorder; Dose-Response Rela | 1990 |
Response of HIV-related depression to psychostimulants: case reports.
Topics: Acquired Immunodeficiency Syndrome; Adult; Depressive Disorder; Dextroamphetamine; Humans; Male; Met | 1988 |
Psychosocial aspects of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Attitude to Health; Brain Diseases; Child; Dementia; Dextroamphe | 1987 |